2025 PRIMO | Immunotherapy and Optimal Chemotherapy for Early Stage TNBC: When and in Whom?
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Hope Rugo, MD, FASCO
Date of Release
May 14th, 2025
-1750785566843.webp&w=3840&q=75)
